Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110974324> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W2110974324 endingPage "726" @default.
- W2110974324 startingPage "715" @default.
- W2110974324 abstract "The mechanism of action, pharmacology, pharmacokinetics, clinical efficacy, drug interactions, adverse effects, dosage and administration, cost, and role in therapy of maraviroc are reviewed.Maraviroc is the first CCR5 coreceptor antagonist to receive marketing approval from the Food and Drug Administration (FDA) for the treatment of CCR5-tropic human immunodeficiency virus (HIV) infection as part of an optimized antiretroviral regimen in treatment-experienced patients. As 50% or more of treatment-experienced patients may be infected with CXCR4-tropic virus, a tropism assay should be performed before initiating maraviroc therapy. The majority of evidence supporting maraviroc's use comes from two studies of HIV-infected, treatment-experienced patients. Pooled analysis from these two studies revealed that twice-daily maraviroc decreased HIV-1 RNA by 1.84 log copies/mL, compared with 0.78 log copy/mL with placebo. Forty-six percent of subjects attained an HIV-1 RNA concentration of <50 copies/mL, compared with only 17% with placebo. In a trial of treatment-naive HIV-infected individuals, maraviroc failed to show noninferiority to efavirenz. Maraviroc is metabolized by cytochrome P-450 isoenzyme 3A4 and is subject to interactions with inhibitors and inducers of that isoenzyme, such as the protease inhibitors (except tipranavir), efavirenz, and rifampin. Resistance has been reported with maraviroc, but specific mechanisms are still poorly understood. The most common adverse effects reported with maraviroc were diarrhea, nausea, fatigue, and headache.Available data support the use of maraviroc, the first CCR5 antagonist to receive FDA marketing approval, as part of an optimized antiretroviral regimen in treatment-experienced patients infected with CCR5-tropic HIV." @default.
- W2110974324 created "2016-06-24" @default.
- W2110974324 creator A5013542994 @default.
- W2110974324 creator A5020404415 @default.
- W2110974324 creator A5089606767 @default.
- W2110974324 date "2009-04-15" @default.
- W2110974324 modified "2023-09-28" @default.
- W2110974324 title "Maraviroc: A coreceptor CCR5 antagonist for management of HIV infection" @default.
- W2110974324 cites W1981440980 @default.
- W2110974324 cites W1981644527 @default.
- W2110974324 cites W1989035987 @default.
- W2110974324 cites W1999048558 @default.
- W2110974324 cites W2039244520 @default.
- W2110974324 cites W2081693798 @default.
- W2110974324 cites W2102690771 @default.
- W2110974324 cites W2117378263 @default.
- W2110974324 cites W2119951120 @default.
- W2110974324 cites W2128618062 @default.
- W2110974324 cites W2164585544 @default.
- W2110974324 cites W2167482040 @default.
- W2110974324 cites W2169054534 @default.
- W2110974324 cites W2172208936 @default.
- W2110974324 doi "https://doi.org/10.2146/ajhp080206" @default.
- W2110974324 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19336831" @default.
- W2110974324 hasPublicationYear "2009" @default.
- W2110974324 type Work @default.
- W2110974324 sameAs 2110974324 @default.
- W2110974324 citedByCount "37" @default.
- W2110974324 countsByYear W21109743242012 @default.
- W2110974324 countsByYear W21109743242013 @default.
- W2110974324 countsByYear W21109743242014 @default.
- W2110974324 countsByYear W21109743242015 @default.
- W2110974324 countsByYear W21109743242017 @default.
- W2110974324 countsByYear W21109743242018 @default.
- W2110974324 countsByYear W21109743242019 @default.
- W2110974324 countsByYear W21109743242021 @default.
- W2110974324 countsByYear W21109743242022 @default.
- W2110974324 countsByYear W21109743242023 @default.
- W2110974324 crossrefType "journal-article" @default.
- W2110974324 hasAuthorship W2110974324A5013542994 @default.
- W2110974324 hasAuthorship W2110974324A5020404415 @default.
- W2110974324 hasAuthorship W2110974324A5089606767 @default.
- W2110974324 hasConcept C126322002 @default.
- W2110974324 hasConcept C12823836 @default.
- W2110974324 hasConcept C13373296 @default.
- W2110974324 hasConcept C142462285 @default.
- W2110974324 hasConcept C159047783 @default.
- W2110974324 hasConcept C197934379 @default.
- W2110974324 hasConcept C2522874641 @default.
- W2110974324 hasConcept C2776914184 @default.
- W2110974324 hasConcept C2778899366 @default.
- W2110974324 hasConcept C2781413609 @default.
- W2110974324 hasConcept C2781432083 @default.
- W2110974324 hasConcept C2993143319 @default.
- W2110974324 hasConcept C3013748606 @default.
- W2110974324 hasConcept C37044404 @default.
- W2110974324 hasConcept C71924100 @default.
- W2110974324 hasConcept C98274493 @default.
- W2110974324 hasConceptScore W2110974324C126322002 @default.
- W2110974324 hasConceptScore W2110974324C12823836 @default.
- W2110974324 hasConceptScore W2110974324C13373296 @default.
- W2110974324 hasConceptScore W2110974324C142462285 @default.
- W2110974324 hasConceptScore W2110974324C159047783 @default.
- W2110974324 hasConceptScore W2110974324C197934379 @default.
- W2110974324 hasConceptScore W2110974324C2522874641 @default.
- W2110974324 hasConceptScore W2110974324C2776914184 @default.
- W2110974324 hasConceptScore W2110974324C2778899366 @default.
- W2110974324 hasConceptScore W2110974324C2781413609 @default.
- W2110974324 hasConceptScore W2110974324C2781432083 @default.
- W2110974324 hasConceptScore W2110974324C2993143319 @default.
- W2110974324 hasConceptScore W2110974324C3013748606 @default.
- W2110974324 hasConceptScore W2110974324C37044404 @default.
- W2110974324 hasConceptScore W2110974324C71924100 @default.
- W2110974324 hasConceptScore W2110974324C98274493 @default.
- W2110974324 hasIssue "8" @default.
- W2110974324 hasLocation W21109743241 @default.
- W2110974324 hasLocation W21109743242 @default.
- W2110974324 hasOpenAccess W2110974324 @default.
- W2110974324 hasPrimaryLocation W21109743241 @default.
- W2110974324 hasRelatedWork W1984714210 @default.
- W2110974324 hasRelatedWork W1988373808 @default.
- W2110974324 hasRelatedWork W1998268937 @default.
- W2110974324 hasRelatedWork W2013838885 @default.
- W2110974324 hasRelatedWork W2053642088 @default.
- W2110974324 hasRelatedWork W2055511351 @default.
- W2110974324 hasRelatedWork W2075064825 @default.
- W2110974324 hasRelatedWork W2082116017 @default.
- W2110974324 hasRelatedWork W2160230582 @default.
- W2110974324 hasRelatedWork W1938396993 @default.
- W2110974324 hasVolume "66" @default.
- W2110974324 isParatext "false" @default.
- W2110974324 isRetracted "false" @default.
- W2110974324 magId "2110974324" @default.
- W2110974324 workType "article" @default.